Open AccessAre the Protective Effects of SGLT2 Inhibitors a “Class-Effect” or Are There Differences between Agents?
Author(s) -
Darren W. Schmidt,
Christos Argyropoulos,
Namita Singh
Publication year - 2021
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0000622021
Subject(s) - medicine , drug class , intensive care medicine , class (philosophy) , clinical trial , drug , pharmacology , computer science , artificial intelligence
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom